Bellus Health Earnings Estimate

BLU
 Stock
  

USD 11.88  0.08  0.67%   

Many public companies, such as Bellus Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Bellus Health's earnings estimates, investors can diagnose different trends across Bellus Health's analyst sentiment over time as well as compare current estimates against different timeframes.
Bellus Health is projected to generate -0.92 in earnings per share on the 31st of December 2021. Bellus Health earnings estimates module stress-tests analyst consensus about projected Bellus Health EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Continue to Trending Equities.
  
Gross Profit is likely to gain to about 16.4 K in 2022, whereas Profit Margin is likely to drop (11.03)  in 2022.

Bellus Health Earnings Estimation Breakdown

Calculation of earning per share of Bellus Health is based on official Zacks consensus of 3 analysts regarding Bellus Health future annual earnings. Given the historical accuracy of 50.4%, the future earnings per share of Bellus Health is estimated to be -0.92 with the lowest and highest values of -1.06 and -0.6, respectively. Please note that this consensus of annual earnings estimates for Bellus Health is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS -0.85
-1.06
Lowest
Expected EPS -0.92
-0.6
Highest

Bellus Health Earnings Projection Consensus

Suppose the current estimates of Bellus Health's value are higher than the current market price of the Bellus Health stock. In this case, investors may conclude that Bellus Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bellus Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2021

3

50.4%

-0.85

-0.92

Bellus Health Earnings per Share Projection vs Actual

Actual Earning per Share of Bellus Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bellus Health predict the company's earnings will be in the future. The higher the earnings per share of Bellus Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Bellus Health Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Bellus Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bellus Health should always be considered in relation to other companies to make a more educated investment decision.

Bellus Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Bellus Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-10
2022-06-30-0.16-0.18-0.0212 
2022-05-11
2022-03-31-0.18-0.130.0527 
2022-02-23
2021-12-31-0.26-0.180.0830 
2021-11-10
2021-09-30-0.22-0.29-0.0731 
2021-08-11
2021-06-30-0.21-0.23-0.02
2021-05-10
2021-03-31-0.14-0.2-0.0642 
2021-02-25
2020-12-31-0.13-0.10.0323 
2020-11-12
2020-09-30-0.14-0.090.0535 
2020-08-13
2020-06-30-0.16-0.140.0212 
2020-05-14
2020-03-31-0.19-0.170.0210 
2020-02-27
2019-12-31-0.13-0.2-0.0753 
2019-11-14
2019-09-30-0.13-0.14-0.01
2019-08-08
2019-06-30-0.0684-0.14-0.0716104 
2019-05-08
2019-03-31-0.0274-0.08-0.0526191 
2019-02-21
2018-12-31-0.0534-0.050.0034
2018-11-14
2018-09-30-0.0553-0.11-0.054798 
2018-08-08
2018-06-30-0.0549-0.040.014927 
2018-05-15
2018-03-31-0.0283-0.07-0.0417147 
2018-02-21
2017-12-31-0.058-0.11-0.05289 
2017-11-08
2017-09-30None-0.0849None
2017-08-09
2017-06-30None0.0107None
2017-05-10
2017-03-31None0.0526None
2017-02-28
2016-12-31None-0.0219None
2016-11-10
2016-09-30None-0.01None
2016-08-09
2016-06-30-0.0562-0.010.046282 
2016-05-12
2016-03-31-0.0278-0.010.017864 
2016-02-24
2015-12-31-0.01310.020.0331252 
2015-11-12
2015-09-30None-0.0111None
2015-08-12
2015-06-30None-0.0263None
2015-05-12
2015-03-31None-0.0028None
2015-02-25
2014-12-31None0.0131None
2014-11-05
2014-09-30None-0.0495None
2014-08-13
2014-06-30None-0.0513None
2014-05-08
2014-03-31None-0.0468None
2014-02-26
2013-12-31None-0.0367None
2013-11-06
2013-09-30None0.0746None
2013-08-07
2013-06-30None-0.0643None
2013-05-16
2013-03-31None-0.0404None
2013-02-27
2012-12-31None-0.0367None
2012-11-08
2012-09-30None-0.0195None
2012-08-08
2012-06-30None-1.3661None
2012-05-15
2012-03-31None-1.2033None
2012-02-23
2011-12-31None-0.0756None
2011-11-09
2011-09-30None-0.2197None
2011-08-08
2011-06-30None-0.1379None
2011-05-11
2011-03-31None-0.2728None
2011-02-23
2010-12-31None-1.9265None
2010-11-10
2010-09-30None-3.0871None
2010-08-09
2010-06-30None-2.906None
2010-05-12
2010-03-31None-2.0878None
2010-02-25
2009-12-31None-3.24None
2009-11-11
2009-09-30None-3.8089None
2009-08-12
2009-06-30None-3.118None
2009-05-06
2009-03-31None-21.3207None
2009-02-26
2008-12-31-22.68-24.84-2.16
2008-11-10
2008-09-30-19.44-23.76-4.3222 
2008-08-05
2008-06-30-20.52-28.08-7.5636 
2008-05-05
2008-03-31-25.92-28.08-2.16
2008-02-20
2007-12-31-22.68-35.64-12.9657 
2007-11-07
2007-09-30-43.03-31.3211.7127 
2007-08-09
2007-06-30-53.01-81-27.9952 
2007-05-08
2007-03-31-47.73-58.32-10.5922 
2007-02-21
2006-12-31-44.67-47.52-2.85
2006-11-08
2006-09-30-43.13-46.44-3.31
2006-08-09
2006-06-30-45.35-50.76-5.4111 
2006-05-09
2006-03-31-44.04-42.121.92
2006-02-23
2005-12-31-49.68-38.8810.821 
2005-11-08
2005-09-30-42.84-51.84-921 
2005-08-10
2005-06-30-44.4-46.44-2.04
2005-05-12
2005-03-31-44.02-46.44-2.42
2005-02-22
2004-12-31-37.08-45.36-8.2822 
2004-11-04
2004-09-30-52.92-37.815.1228 
2004-08-17
2004-06-30-34.99-38.83-3.8410 
2004-05-11
2004-03-31-23.28-24.2-0.92
2004-02-23
2003-12-31-17.66-11.286.3836 
2003-11-12
2003-09-30-17.28-20.57-3.2919 
2003-08-18
2003-06-30-21.02-23.88-2.8613 
2003-05-14
2003-03-31-20.18-15.524.6623 

About Bellus Health Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Bellus Health earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Bellus Health estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Bellus Health fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit-554.3 M-598.1 M
Earning Before Interest and Taxes EBIT-71.4 M-73.2 M
Earnings per Basic Share(0.90) (0.92) 
Earnings per Diluted Share(0.90) (0.92) 
Price to Earnings Ratio(11.45) (12.35) 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA-71.2 M-73 M
Earnings before Tax-71.4 M-73.3 M
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Bellus Health Investors Sentiment

The influence of Bellus Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bellus. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Bellus Health's public news can be used to forecast risks associated with investment in Bellus. The trend in average sentiment can be used to explain how an investor holding Bellus can time the market purely based on public headlines and social activities around Bellus Health. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Bellus Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bellus Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bellus Health's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Bellus Health.

Bellus Health Implied Volatility

    
  240.48  
Bellus Health's implied volatility exposes the market's sentiment of Bellus Health stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bellus Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bellus Health stock will not fluctuate a lot when Bellus Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bellus Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bellus Health's short interest history, or implied volatility extrapolated from Bellus Health options trading.

Pair Trading with Bellus Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bellus Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bellus Health

0.7ACXPAcurx Pharmaceuticals Earnings Call  TodayPairCorr
0.79ALXOAlx Oncology Holdings Aggressive PushPairCorr

Moving against Bellus Health

0.71ADMTAdm Tronics Unlimited Earnings Call  This WeekPairCorr
0.7ATHAAthira Pharma Earnings Call  TodayPairCorr
0.54AGTCApplied Genetic Tech Fiscal Year End 22nd of September 2022 PairCorr
The ability to find closely correlated positions to Bellus Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellus Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellus Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellus Health to buy it.
The correlation of Bellus Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bellus Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bellus Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bellus Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.5 B
Return On Assets
-0.22
Return On Equity
-0.37
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.